dalteparin has been researched along with Cholestasis in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Cholestasis: Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levinson, P | 1 |
| Glaumann, H | 1 |
| Söderberg, M | 1 |
1 other study available for dalteparin and Cholestasis
| Article | Year |
|---|---|
Probable dalteparin-induced hepatotoxicity in a man with alpha-1-antitrypsin deficiency.
Topics: alpha 1-Antitrypsin Deficiency; Anticoagulants; Chemical and Drug Induced Liver Injury; Cholestasis; | 2012 |